Lab Reference Library / Urinary N-Methylhistamine Inflammation and Immune

Urinary N-Methylhistamine

Q: How is urinary N-methylhistamine collected?

A 24-hour urine collection is the standard method. The patient collects all urine over a 24-hour period into a container provided by the laboratory, which is kept refrigerated throughout the collection. Some laboratories offer a spot urine NMH/creatinine ratio as an alternative, which is more convenient but less comprehensive. For MCAS evaluation, the 24-hour collection is preferred because it captures the full daily histamine burden. Patients should avoid high-histamine foods for 24 hours before and during collection to reduce dietary confounding.

Q: What does elevated urinary NMH mean?

Elevated urinary NMH indicates excessive total daily histamine production. The sources include mast cell degranulation (MCAS or mastocytosis), basophil activation, histamine-producing gut bacteria (gut dysbiosis), excessive dietary histamine intake, and impaired histamine degradation (DAO deficiency or HNMT polymorphisms). Clinical correlation with symptoms, tryptase, prostaglandin D2 metabolites, and dietary history determines the primary source. Elevated NMH with normal tryptase suggests histamine-predominant mast cell activation or histamine intolerance rather than mastocytosis.

Q: Can diet affect urinary N-methylhistamine results?

Yes. High-histamine foods (aged cheese, fermented foods, cured meats, wine, beer, leftover proteins, certain fish) contribute dietary histamine that is absorbed, metabolized to NMH, and excreted in urine. Patients should follow a low-histamine diet for 24 hours before and during the collection to isolate endogenous histamine production from dietary sources. If NMH remains elevated on a low-histamine diet, the source is endogenous (mast cells, basophils, or histamine-producing bacteria) rather than dietary.

NMH · N-Methylhistamine · Urine Histamine Metabolite

Reference range, clinical significance, and why urinary N-methylhistamine is the most reliable marker of total daily histamine production. Unlike plasma histamine (which has a half-life of minutes and is nearly impossible to capture accurately), NMH accumulates in urine over a 24-hour collection and reflects the integrated histamine burden from mast cells, basophils, and dietary sources combined.

Mast Cell MediatorMCAS Evaluation

24-hr Reference30 to 200 mcg/24hr

Spot UrineLab-specific ratio

Collection24-hr or spot

Keep RefrigeratedYes

← Back to Lab Reference Library

Category: Inflammation and Immune | Also known as: NMH, N-Methylhistamine, Urine Histamine Metabolite | Sample: 24-hour urine collection (refrigerated) or spot urine with creatinine correction

1. What This Test Measures

Urinary N-methylhistamine (NMH) is the primary metabolite of histamine, produced through the intracellular degradation pathway catalyzed by histamine N-methyltransferase (HNMT). Approximately 70 to 80% of histamine is metabolized through this pathway (the remainder is degraded by diamine oxidase, DAO, in the extracellular/intestinal pathway). NMH is subsequently oxidized to N-methylimidazole acetic acid by monoamine oxidase B (MAO-B) and excreted in urine.

The critical advantage of urinary NMH over plasma histamine is the integration window. Plasma histamine has a half-life of approximately 1 to 2 minutes. A blood draw captures a single moment; if the patient is not actively degranulating mast cells at that exact moment, plasma histamine will be normal regardless of how much histamine was produced over the preceding hours. Urinary NMH, collected over 24 hours, captures the cumulative histamine burden from the entire day. A patient who has multiple brief mast cell activation episodes throughout the day will show elevated 24-hour NMH even though each individual plasma histamine spike lasted only minutes and would have been missed by a single blood draw.

Urinary NMH reflects histamine from all sources: mast cell degranulation (the primary endogenous source in MCAS and mastocytosis), basophil activation, histamine-producing gut bacteria (certain species of Enterobacteriaceae, Lactobacillus, and others produce histamine from dietary histidine), gastric enterochromaffin-like (ECL) cell secretion (physiological acid regulation), and dietary histamine absorption. Distinguishing between these sources requires clinical correlation with symptoms, tryptase, dietary history, and gut assessment.

2. Why This Test Matters

MCAS mediator documentation: elevated urinary NMH is one of the accepted mediator criteria for mast cell activation syndrome diagnosis. Many MCAS patients have normal tryptase because their mast cell number is normal; the problem is inappropriate activation with histamine as the predominant mediator. NMH catches these histamine-predominant presentations that tryptase misses
Histamine intolerance assessment: patients with impaired DAO activity (genetic DAO polymorphisms, DAO-inhibiting medications, or gut mucosal damage reducing intestinal DAO) accumulate dietary histamine that would normally be degraded before absorption. Elevated NMH in a patient whose symptoms correlate with high-histamine food intake suggests histamine intolerance
Mastocytosis monitoring: in systemic mastocytosis (persistently elevated tryptase above 20 ng/mL), urinary NMH tracks the histamine component of disease activity and monitors response to mast cell stabilization therapy
Gut dysbiosis contribution: certain gut bacteria produce histamine from the amino acid histidine. In patients with gut permeability and dysbiosis, this bacterially-produced histamine enters the bloodstream, is metabolized to NMH, and contributes to histamine symptoms. Elevated NMH that normalizes with gut restoration and probiotic modulation points to this mechanism
Treatment response monitoring: serial NMH measurements track the response to H1/H2 antihistamine therapy, mast cell stabilizers (quercetin, cromolyn), DAO supplementation, low-histamine diet, and gut restoration protocols
Complements tryptase and PGD2: the mast cell mediator panel (tryptase, NMH, prostaglandin D2 metabolites) casts a wider net than any single marker. Tryptase catches mast cell number and degranulation events; NMH catches histamine-predominant activation; PGD2 catches prostaglandin-predominant activation

3. Standard Lab Reference Range

Collection Type	Reference Range	Notes
24-hour urine	30 to 200 mcg/24hr	Most reliable; integrates full daily histamine production; refrigerate during collection
Spot urine (NMH/Cr)	Lab-specific ratio	More convenient; corrected for creatinine; less comprehensive than 24-hour

4. Functional Medicine Interpretation

NMH Level	Interpretation	Clinical Action
Below 100 mcg/24hr	Normal histamine production; MCAS histamine pathway unlikely	If MCAS suspected, evaluate PGD2 metabolites and tryptase
100 to 200 mcg/24hr	Upper normal; consider dietary histamine contribution	Repeat on low-histamine diet; if still elevated, endogenous source likely
200 to 500 mcg/24hr	Elevated; excessive histamine production confirmed	Distinguish mast cell activation from dietary/gut source; correlate with tryptase and symptoms
Above 500 mcg/24hr	Significantly elevated; strong evidence of mast cell mediator excess	Full MCAS/mastocytosis evaluation; mast cell stabilization protocol

The dietary confound: a patient eating aged cheese, cured meats, fermented vegetables, and drinking red wine during the collection will have elevated NMH from dietary histamine absorption, not from mast cell disease. This is why a 24-hour low-histamine dietary preparation before and during collection is essential for accurate interpretation. If NMH normalizes on a low-histamine diet, the problem is dietary histamine and/or impaired DAO degradation, not endogenous mast cell overproduction.

5. Urinary NMH in the Complete Mast Cell Mediator Panel

Marker	What It Catches	Collection
Urinary NMH (this page)	Total daily histamine production from all sources	24-hr urine, refrigerated
Serum Tryptase	Mast cell burden (baseline) and degranulation (acute)	Serum; baseline + acute within 1 to 4 hr
Urinary PGD2 Metabolite	Mast cell-specific prostaglandin; prostaglandin-predominant MCAS	Spot or 24-hr urine
Plasma Histamine	Immediate histamine release; very short half-life	Blood on ice; process within 15 min
hs-CRP	Systemic inflammation context; mast cells contribute to inflammation	Serum; any time
Total IgE	Allergic sensitization status; distinguishes allergy from MCAS	Serum; any time

6. Symptoms Associated With Elevated Histamine

Histamine Receptor H1 Symptoms

Flushing (face, neck, upper chest)
Urticaria (hives) and pruritus (itching)
Nasal congestion and rhinorrhea
Headache (histamine-mediated vasodilation)
Bronchoconstriction (wheezing, chest tightness)
Tachycardia and palpitations
Anxiety, insomnia (CNS H1 receptor activation)
Hypotension during severe episodes

Histamine Receptor H2 and Systemic

Gastric acid hypersecretion and reflux
Abdominal pain and cramping
Diarrhea (GI motility stimulation)
Nausea after meals (especially high-histamine foods)
Dysmenorrhea (uterine smooth muscle contraction)
Brain fog and cognitive impairment
Exercise intolerance with flushing or hives
Reactions to alcohol (histamine in fermented beverages plus DAO inhibition)

7. What Causes Elevated Urinary NMH

Mast cell activation syndrome (MCAS): inappropriate mast cell degranulation releases histamine as a predominant mediator. Many MCAS patients present with histamine-predominant symptoms (flushing, urticaria, GI dysfunction) and elevated NMH with normal tryptase
Systemic mastocytosis: increased mast cell number produces constitutively elevated histamine release. NMH is typically elevated alongside persistently elevated tryptase above 20 ng/mL
Dietary histamine excess: high-histamine foods (aged cheese, wine, fermented foods, cured meats, leftover proteins) contribute absorbed histamine that is metabolized to NMH. This is the most common non-pathological cause of elevated NMH
DAO deficiency: diamine oxidase is the primary enzyme degrading extracellular and dietary histamine in the gut. Genetic DAO polymorphisms, gut mucosal damage (intestinal permeability), and DAO-inhibiting medications (alcohol, NSAIDs, certain antibiotics) reduce histamine degradation capacity
Histamine-producing gut bacteria: certain bacterial species (Klebsiella, Morganella, some Lactobacillus strains, Enterobacter) produce histamine from dietary histidine through bacterial histidine decarboxylase. Gut dysbiosis with overgrowth of these species increases endogenous histamine production
Medications: opioids, NSAIDs, certain muscle relaxants, vancomycin, and contrast dye can trigger mast cell degranulation and elevate histamine
HNMT polymorphisms: genetic variants in histamine N-methyltransferase reduce the rate of intracellular histamine methylation, potentially increasing histamine levels at the tissue level

8. How to Reduce Histamine Burden

Dietary Management

Low-histamine diet (4 to 8 week trial): eliminate aged cheeses, fermented foods, cured and smoked meats, wine, beer, vinegar, leftover proteins, canned fish, and high-histamine fruits (citrus, strawberries, tomatoes)
Freshness principle: eat proteins fresh or from frozen. Histamine accumulates in protein as bacteria convert histidine to histamine during storage
DAO supplementation (before meals): diamine oxidase enzyme supplement taken 15 minutes before meals breaks down dietary histamine in the gut before absorption
Identify and rotate trigger foods: after the elimination phase, reintroduce foods individually to identify personal triggers

Mast Cell Stabilization

Quercetin (500mg twice daily): natural mast cell stabilizer that inhibits degranulation and reduces histamine release at the source
H1 antihistamine (cetirizine 10mg twice daily): blocks histamine at H1 receptors; reduces flushing, urticaria, pruritus, and CNS symptoms
H2 antihistamine (famotidine 20mg twice daily): blocks histamine at H2 receptors; reduces gastric acid, GI symptoms
Cromolyn sodium (oral, 100 to 200mg before meals): pharmaceutical mast cell stabilizer for GI-predominant histamine symptoms
Vitamin C (1000 to 2000mg daily): promotes histamine degradation through DAO cofactor support

Gut and Root Cause

Gut barrier restoration: intestinal permeability repair with L-glutamine, zinc carnosine, and immunoglobulin support reduces histamine translocation
Address gut dysbiosis: comprehensive stool analysis identifies histamine-producing bacteria. Favor histamine-degrading probiotic strains (L. rhamnosus, B. infantis) over histamine-producing strains (L. casei, L. bulgaricus)
Zinc (30mg daily): DAO cofactor; zinc deficiency impairs histamine degradation
B6 (P-5-P, 50 to 100mg daily): cofactor for both DAO and HNMT histamine degradation pathways
Stress reduction: corticotropin-releasing hormone directly activates mast cells; chronic stress perpetuates the activation cycle

9. Related Lab Tests

Serum TryptaseMast Cell Burden and Degranulation Marker

→

hs-CRPSystemic Inflammation Context

→

ZincDAO Cofactor; Histamine Degradation Support

→

Vitamin DImmune Modulation; Mast Cell Regulation

→

CortisolStress Axis; CRH Activates Mast Cells

→

FerritinElevated in Mastocytosis and Chronic Activation

→

10. When Testing Is Recommended

Suspected MCAS with normal tryptase: NMH catches histamine-predominant mast cell activation that tryptase-only testing misses
Comprehensive mast cell mediator panel: alongside tryptase, prostaglandin D2 metabolites, and plasma histamine for maximum diagnostic sensitivity
Suspected histamine intolerance: symptoms correlating with high-histamine food intake (flushing, headache, GI symptoms, urticaria after wine, cheese, fermented foods)
Chronic unexplained urticaria, flushing, or GI symptoms not explained by standard allergy testing
Monitoring treatment response to mast cell stabilizers, antihistamines, low-histamine diet, and gut restoration protocols
Known MCAS or mastocytosis: serial NMH tracks histamine mediator burden and treatment efficacy
Patients with gut permeability and suspected histamine-producing bacterial overgrowth
Collection instructions: 24-hour urine, refrigerated throughout; low-histamine diet for 24 hours before and during collection; discuss antihistamine discontinuation with physician before collection

11. Clinical Perspective

Clinical Perspective

When tryptase is normal and I still suspect mast cell activation, urinary N-methylhistamine is where I look next. Many of my MCAS patients have a normal mast cell number. Their tryptase is 5, their mast cells look normal in quantity, but those mast cells are releasing histamine at the wrong times and in response to the wrong triggers. The NMH captures what tryptase cannot: the total daily histamine burden from a mast cell population that looks normal in number but is behaving abnormally. I always run NMH on a low-histamine dietary preparation. If the patient has been eating sauerkraut and aged cheddar and drinking Pinot Noir the day before the collection, I cannot distinguish dietary histamine from mast cell histamine. But if NMH is elevated after 24 hours of strict dietary avoidance, I know the source is endogenous, and I know where to focus the treatment.

Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma

12. Frequently Asked Questions

What is urinary N-methylhistamine?

The primary metabolite of histamine, produced by HNMT. A 24-hour urine collection integrates total daily histamine production from all sources: mast cells, basophils, gut bacteria, and diet. More reliable than plasma histamine (half-life 1 to 2 minutes) because it captures the cumulative burden rather than a single-moment snapshot.

Why is urinary NMH better than plasma histamine?

Plasma histamine has a 1 to 2 minute half-life, requires ice and immediate processing, and captures only a single moment. NMH accumulates over 24 hours, catching every histamine spike regardless of timing. A patient with three brief activation episodes during the day will show elevated NMH even though each plasma spike would have been missed by a single blood draw.

How is urinary N-methylhistamine collected?

24-hour urine collection, refrigerated throughout, is the standard. Some labs offer spot urine NMH/creatinine ratio (more convenient, less comprehensive). Follow a low-histamine diet for 24 hours before and during collection to reduce dietary confounding. Discuss antihistamine discontinuation with your physician before collection.

What does elevated urinary NMH mean?

Excessive total daily histamine production. Sources include mast cell activation (MCAS, mastocytosis), dietary histamine, DAO deficiency (impaired gut histamine degradation), histamine-producing gut bacteria (dysbiosis), and medications triggering degranulation. Clinical correlation determines the primary source. Elevated NMH with normal tryptase suggests histamine-predominant activation.

Can diet affect urinary N-methylhistamine results?

Yes. High-histamine foods (aged cheese, fermented foods, wine, cured meats, leftover proteins) contribute dietary histamine metabolized to NMH. A 24-hour low-histamine dietary preparation is essential. If NMH normalizes on low-histamine diet, the source is dietary/DAO deficiency rather than endogenous mast cell overproduction.

Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.

Urinary NMH captures the total daily histamine burden that plasma histamine and tryptase alone cannot.

The complete mast cell mediator panel includes tryptase, N-methylhistamine, and prostaglandin D2 metabolites. Cast the widest net to identify histamine-predominant activation and guide targeted treatment. Schedule a consultation at The Lamkin Clinic.

Schedule a Consultation

Medical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Mast cell mediator testing requires proper collection technique, dietary preparation, and clinical interpretation. Lab interpretation should always be performed by a qualified healthcare provider. Schedule a consultation to discuss your specific results with Brian Lamkin, DO.